Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Inagaki

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 12, 2008
[Strategies for regulating allergic responses]Naoki Inagaki
Arerugi = [Allergy]|February 3, 2007
[What should we learn from animal models?]Naoki Inagaki
Nihon Jibiinkoka Gakkai Kaiho|July 15, 2009
[Clinico-pharmacology of glucocorticoids]Naoki Inagaki
Biological & Pharmaceutical Bulletin|August 2, 2013
ForewordNaoki Inagaki
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|April 6, 2006
[Evaluation of drugs for the treatment of atopic dermatitis in mice]Naoki Inagaki, Hiroichi Nagai
Journal of Pharmacological Sciences|July 18, 2009
Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment:mouse models for the development of remedies for human allergic dermatitisNaoki Inagaki, Hiroichi Nagai
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|May 10, 2017
Epithelial barrier function and innate immunity - their involvement in the pathophysiology of allergy and the therapeutic targetsHiroyuki Tanaka, Hirotaka Yamashita, Naoki Inagaki
Biological & Pharmaceutical Bulletin|August 2, 2013
Treatment of the chronic itch of atopic dermatitis using standard drugs and kampo medicinesHirotaka Yamashita, Hiroyuki Tanaka, Naoki Inagaki
Biological & Pharmaceutical Bulletin|May 9, 2003
Effects of prednisolone on the cutaneous reaction and skin barrier function in mice treated with a haptenYoshifumi Ueda, Toshiro Sone, Naoki Inagaki, et al.
Redox Report : Communications in Free Radical Research|July 3, 2010
The effect of hypoxia mimetic cobalt chloride on the expression of EC-SOD in 3T3-L1 adipocytesTetsuro Kamiya, Hirokazu Hara, Naoki Inagaki, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 12, 2008
[Strategies for regulating allergic responses]Naoki Inagaki
Arerugi = [Allergy]|February 3, 2007
[What should we learn from animal models?]Naoki Inagaki
Nihon Jibiinkoka Gakkai Kaiho|July 15, 2009
[Clinico-pharmacology of glucocorticoids]Naoki Inagaki
Biological & Pharmaceutical Bulletin|August 2, 2013
ForewordNaoki Inagaki
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|April 6, 2006
[Evaluation of drugs for the treatment of atopic dermatitis in mice]Naoki Inagaki, Hiroichi Nagai
Journal of Pharmacological Sciences|July 18, 2009
Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment:mouse models for the development of remedies for human allergic dermatitisNaoki Inagaki, Hiroichi Nagai
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|May 10, 2017
Epithelial barrier function and innate immunity - their involvement in the pathophysiology of allergy and the therapeutic targetsHiroyuki Tanaka, Hirotaka Yamashita, Naoki Inagaki
Biological & Pharmaceutical Bulletin|August 2, 2013
Treatment of the chronic itch of atopic dermatitis using standard drugs and kampo medicinesHirotaka Yamashita, Hiroyuki Tanaka, Naoki Inagaki
Biological & Pharmaceutical Bulletin|May 9, 2003
Effects of prednisolone on the cutaneous reaction and skin barrier function in mice treated with a haptenYoshifumi Ueda, Toshiro Sone, Naoki Inagaki, et al.
Redox Report : Communications in Free Radical Research|July 3, 2010
The effect of hypoxia mimetic cobalt chloride on the expression of EC-SOD in 3T3-L1 adipocytesTetsuro Kamiya, Hirokazu Hara, Naoki Inagaki, et al.
Pageof 9